Document is current
Any future updates will be listed below
-
Authors
Nonomiya, Yuta https://orcid.org/0000-0003-0511-0244
Morimatsu, Hiroshi
Kuriu, Kaori
Kabata, Daijiro
Shintani, Ayumi
- License Information
-
More Information
Article History
Received: 8 September 2024
Accepted: 21 May 2025
First Online: 7 June 2025
Declarations
:
: Yuta Nonomiya is receiving a fellowship for the Next Generation AI Human Resource Development Project of Osaka Metropolitan University; Hiroshi Morimatsu has no conflict of interest; Kaori Kuriu has no conflict of interest; Daijiro Kabata has no conflict of interest; Ayumi Shintani is receiving personal fees from AbbVie, Asahi Kasei Corporation, AstraZeneca plc, Astellas Pharma, Bayer Yakuhin, Bristol Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Janssen Pharmaceutical, Kissei Pharmaceutical, Kyowa Kirin, Mallinckrodt Pharmaceuticals, Merck Biopharma, Maruho, Mitsubishi Tanabe Pharma Corporation, Nipro Corporation, Novo Nordisk Pharma, Nippon Shinyaku, Ono Pharmaceutical, Pfizer, Shionogi Pharma, Takeda Pharmaceutical Company Limited, Taisho Pharmaceutical, Torii Pharmaceutical, Sanofi K.K., Nippon Kayaku, JCR Pharmaceuticals Co., and MSD.
